South Africa's largest generic drug company Enaleni Pharmaceuticals is planning to sue Lupin - the Rs 1,200 crore (Rs 12 billion) domestic pharma major - for terminating a marketing right unilaterally in violation of an existing agreement.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances